Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023044 |
---|---|
Receipt number | R000026558 |
Scientific Title | The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease. |
Date of disclosure of the study information | 2016/10/21 |
Last modified on | 2018/12/10 18:53:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/07/06 17:22:26 | ||
2 | Update | 2016/07/07 18:07:53 | UMIN ID1 |
|
3 | Update | 2016/07/14 16:12:06 | Key secondary outcomes |
|
4 | Update | 2016/07/14 16:13:46 | Division Date of disclosure of the study information |
|
5 | Update | 2016/09/01 10:28:10 | Condition Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
6 | Update | 2016/09/01 10:29:12 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2016/09/01 10:33:42 | Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2016/10/14 15:11:04 | Key secondary outcomes |
|
9 | Update | 2016/10/14 15:19:12 | Date of disclosure of the study information |
|
10 | Update | 2016/10/31 13:58:48 | Date of protocol fixation Anticipated trial start date |
|
11 | Update | 2016/11/28 10:07:16 | Recruitment status Anticipated trial start date |
|
12 | Update | 2016/11/29 11:02:19 | Recruitment status |
|
13 | Update | 2017/08/03 14:19:56 | Recruitment status |
|
14 | Update | 2018/07/09 08:36:57 | Recruitment status |
|
15 | Update | 2018/12/10 18:53:07 | Publication of results URL related to results and publications |